Article Details

Arbutus Biopharma (NASDAQ:ABUS) Rating Increased to Hold at StockNews.com

Retrieved on: 2025-03-30 06:51:45

Tags for this article:

Click the tags to see associated articles and topics

Arbutus Biopharma (NASDAQ:ABUS) Rating Increased to Hold at StockNews.com. View article details on hiswai:

Excerpt

StockNews.com upgraded Arbutus Biopharma from a "sell" rating to a "hold" rating in a report on Saturday.

Article found on: www.marketbeat.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo